Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus

The Cancer Genetic Markers of Susceptibility genome-wide association study (GWAS) originally identified a single nucleotide polymorphism (SNP) rs11249433 at 1p11.2 associated with breast cancer risk. To fine-map this locus, we genotyped 92 SNPs in a 900kb region (120,505,799–121,481,132) flanking rs11249433 in 45,276 breast cancer cases and 48,998 controls of European, Asian and African ancestry from 50 studies in the Breast Cancer Association Consortium. Genotyping was done using iCOGS, a custom-built array. Due to the complicated nature of the region on chr1p11.2: 120,300,000–120,505,798, that lies near the centromere and contains seven duplicated genomic segments, we restricted analyses to 429 SNPs excluding the duplicated regions (42 genotyped and 387 imputed). Per-allelic associations with breast cancer risk were estimated using logistic regression models adjusting for study and ancestry-specific principal components. The strongest association observed was with the original identified index SNP rs11249433 (minor allele frequency (MAF) 0.402; per-allele odds ratio (OR) = 1.10, 95% confidence interval (CI) 1.08–1.13, P = 1.49 x 10-21). The association for rs11249433 was limited to ER-positive breast cancers (test for heterogeneity P≤8.41 x 10-5). Additional analyses by other tumor characteristics showed stronger associations with moderately/well differentiated tumors and tumors of lobular histology. Although no significant eQTL associations were observed, in silico analyses showed that rs11249433 was located in a region that is likely a weak enhancer/promoter. Fine-mapping analysis of the 1p11.2 breast cancer susceptibility locus confirms this region to be limited to risk to cancers that are ER-positive.

S. Cross | M. Beckmann | P. Fasching | A. Børresen-Dale | C. Vachon | Jingmei Li | K. Czene | P. Hall | F. Couch | H. Brenner | J. Chang-Claude | S. Chanock | M. García-Closas | J. Benítez | Sofia Khan | G. Giles | J. Hopper | C. Haiman | T. Dörk | M. Southey | A. Lophatananon | L. Marchand | A. Cox | D. Easton | A. Hollestelle | J. Martens | Chen-Yang Shen | A. Broeks | P. Pharoah | Kai Yu | N. Orr | L. Prokunina-Olsson | H. Brauch | V. Kristensen | X. Shu | Charles C. Chung | W. Zheng | H. Anton-Culver | P. Guénel | W. Blot | A. Dunning | P. Brennan | S. Sangrajrang | O. Fletcher | N. Johnson | G. Chenevix-Trench | S. Bojesen | H. Nevanlinna | D. Kang | N. Bogdanova | P. Devilee | R. Milne | A. González-Neira | U. Hamann | A. Mannermaa | V. Kosma | M. Shah | K. Muir | A. Lindblom | K. Michailidou | J. Dennis | M. Schmidt | M. Bolla | Qin Wang | A. Meindl | R. Schmutzler | C. Luccarini | H. Flyger | A. Rudolph | T. Truong | F. Marmé | B. Burwinkel | E. Sawyer | I. Tomlinson | I. Andrulis | J. Knight | S. Margolin | V. Arndt | A. Swerdlow | J. Figueroa | M. Goldberg | R. Winqvist | A. Jukkola-Vuorinen | P. Radice | C. Seynaeve | A. Jakubowska | J. Lubiński | S. Slager | K. Matsuo | H. Iwata | A. Wu | S. Teo | M. Hartman | Q. Cai | M. Shrubsole | J. Simard | H. Darabi | S. Neuhausen | D. Torres | D. Yannoukakos | C. Baynes | K. Chia | M. Hou | N. Taib | A. Smeets | M. Kabisch | W. Lu | Ji-Yeob Choi | M. Barile | Han Zhang | Hui Zhao | P. Harrington | Hisani N. Horne | David ven den Berg

[1]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[2]  Peter C Scacheri,et al.  Enhancer variants: evaluating functions in common disease , 2014, Genome Medicine.

[3]  D. Noh,et al.  Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1 , 2014, Nature Genetics.

[4]  Jane E. Carpenter,et al.  Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. , 2014, Carcinogenesis.

[5]  Hong Yang,et al.  Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-κB Activation , 2014, PloS one.

[6]  Julian Peto,et al.  Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast , 2014, PLoS genetics.

[7]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[8]  T. Das,et al.  Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells , 2013, British Journal of Cancer.

[9]  Qian Chen,et al.  Assessing Interactions between the Association of Common Genetic Variant at 1p11 (rs11249433) and Hormone Receptor Status with Breast Cancer Risk , 2013, PloS one.

[10]  Hongwei Zhang,et al.  Association between 1p11-rs11249433 Polymorphism and Breast Cancer Susceptibility: Evidence from 15 Case-Control Studies , 2013, PloS one.

[11]  Wei Zheng,et al.  Evaluating Genome-Wide Association Study-Identified Breast Cancer Risk Variants in African-American Women , 2013, PloS one.

[12]  Jaana M. Hartikainen,et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.

[13]  Wei Lu,et al.  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer , 2013, Nature Genetics.

[14]  Patrick Neven,et al.  Genome-wide association studies identify four ER negative–specific breast cancer risk loci , 2013, Nature Genetics.

[15]  Stephen M. Hewitt,et al.  Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression , 2013, Breast Cancer Research and Treatment.

[16]  Jane E. Carpenter,et al.  A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. , 2012, Human molecular genetics.

[17]  D. Noh,et al.  Genome-Wide Association Study in East Asians Identifies Novel Susceptibility Loci for Breast Cancer , 2012, PLoS genetics.

[18]  Michael Jones,et al.  Genome-wide association analysis identifies three new breast cancer susceptibility loci , 2012, Nature Genetics.

[19]  Jane E. Carpenter,et al.  A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer , 2011, Nature Genetics.

[20]  Hongbing Shen,et al.  Genetic Variants at 1p11.2 and Breast Cancer Risk: A Two-Stage Study in Chinese Women , 2011, PloS one.

[21]  Michael Jones,et al.  Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. , 2011, Human molecular genetics.

[22]  Michael Jones,et al.  Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. , 2011, Journal of the National Cancer Institute.

[23]  Peter H. Sudmant,et al.  Diversity of Human Copy Number Variation and Multicopy Genes , 2010, Science.

[24]  Christiana Kartsonaki,et al.  A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population , 2010, Nature Genetics.

[25]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[26]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[27]  Deborah Hughes,et al.  Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.

[28]  Ashraful Hoque,et al.  Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies , 2010, Human mutation.

[29]  K. Mimori,et al.  Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors. , 2009, Oncology reports.

[30]  C. E. Pearson,et al.  Table S2: Trans-factors and trinucleotide repeat instability Trans-factor , 2010 .

[31]  A. Børresen-Dale,et al.  NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations , 2010, Molecular Cancer.

[32]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[33]  M. Thun,et al.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.

[34]  W. Willett,et al.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) , 2009, Nature Genetics.

[35]  J. Haines,et al.  Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1 , 2009, Nature Genetics.

[36]  J. Visvader,et al.  Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. , 2008, Cell stem cell.

[37]  A. Sigurdsson,et al.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.

[38]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[39]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[40]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[41]  Fangting Wu,et al.  Notch signaling and its role in breast cancer. , 2007, Frontiers in bioscience : a journal and virtual library.

[42]  Augustin Luna,et al.  snp.plotter: an R-based SNP/haplotype association and linkage disequilibrium plotting package , 2007, Bioinform..

[43]  G. Watkins,et al.  The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. , 2004, International journal of molecular medicine.

[44]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.